MedTrace Logo

Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

NCT00874809 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-08-27

No results posted yet for this study

Summary

The main purpose of this study is to determine the number of daily basal insulin rate changes that are needed to achieve short-term near normal glucose control in insulin pump patients with type 2 diabetes

Conditions

Interventions

DEVICE

CGMS with an insulin pump using rapid acting insulin

To determine basal changes subject will wear a CGMS with an insulin pump infusing rapid acting insulin

Sponsors & Collaborators

  • Animas Corporation

    collaborator INDUSTRY

  • Diabetes Care Center

    lead INDUSTRY

Principal Investigators

  • Allen B King, MD · Diabetes Care Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874809 on ClinicalTrials.gov